Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)

SHE:002581 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 3, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	4,994	7,020	9,632	10,391	14,085	12,093
Market Cap Growth	-32.35%	-27.12%	-7.30%	-26.23%	16.48%	153.18%
Enterprise Value	4,863	6,706	9,536	10,515	14,117	12,037
Last Close Price	7.57	10.64	14.60	15.75	21.35	18.33
PE Ratio	-	-	-	-	51.98	-
PS Ratio	19.38	19.48	22.41	29.10	34.98	43.68
PB Ratio	2.51	3.47	4.43	4.19	5.70	5.52
P/TBV Ratio	2.82	3.84	4.91	4.60	6.25	6.13
P/OCF Ratio	-	-	-	-	-	653.31
EV/Sales Ratio	18.87	18.61	22.19	29.45	35.05	43.48
EV/FCF Ratio	-16.32	-	-	-	-	-
Debt / Equity Ratio	0.04	0.00	0.01	0.07	0.07	0.08
Asset Turnover	0.11	0.16	0.17	0.13	0.16	0.09
Inventory Turnover	1.52	1.06	1.13	1.06	1.27	0.80
Quick Ratio	3.41	7.89	3.02	1.05	1.83	3.17
Current Ratio	4.20	9.04	3.72	1.42	2.20	3.70
Return on Equity (ROE)	-12.43%	-6.81%	-13.84%	-0.03%	11.96%	-8.65%
Return on Assets (ROA)	-5.39%	-2.50%	-3.74%	-3.90%	-4.90%	-5.55%
Return on Invested Capital (ROIC)	-12.04%	-5.11%	-6.93%	0.48%	-9.00%	-12.24%
Return on Capital Employed (ROCE)	-9.60%	-4.30%	-7.10%	-7.00%	-8.20%	-11.60%
Earnings Yield	-4.42%	-1.96%	-3.45%	-0.14%	1.92%	-1.62%
FCF Yield	-5.97%	-0.22%	-0.42%	-0.83%	-0.76%	-0.41%
Payout Ratio	-	-	-	-	2.48%	-
Buyback Yield / Dilution	-0.28%	-0.01%	-0.22%	0.21%	0.00%	-0.02%
Total Shareholder Return	-0.28%	-0.01%	-0.22%	0.21%	0.00%	-0.02%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.